This study evaluated perceived effectiveness of an interprofessional case-based activity that allowed medical and pharmacy students to engage in problem-solving around the role of social determinants of health (SDOH) in opioid misuse. Students participated in a case-based activity, and then completed a post-activity survey that included five open-ended questions and the Interprofessional Collaborative Competency Attainment Survey. Twelve pharmacy students (100%) and 47 medical students (75%) completed the post-activity survey. Results indicate the activity resulted in a statistically significant increase in student ability to: 1) recognize interprofessional team members’ knowledge, skills, and contributions to the interprofessional team; 2) communicate effectively across professions; and 3) learn with, from, and about interprofessional team members to develop a patient care plan. Students also reported enhanced understanding of treatment considerations with opioid misuse, the role of SDOH, and recognition of the value of interprofessional collaboration in their future practice. This interprofessional case-based activity appeared to promote collaboration among students from different professional programs as they engaged in problem-solving around a contemporary public health issue that intersects their future practices. This activity may serve as a model for health professional programs, practitioners, healthcare systems, and communities that seek interprofessional solutions to combat opioid misuse.
8 May 2019 in JACCP: Journal of the American College of Clinical Pharmacy
Introduction: Although the opioid crisis has been acknowledged as a public health emergency that requires collaboration and engagement from pharmacists, the perceptions of pharmacists on their role in harm reduction strategies and their views on opioid use have not been well established.Objectives: The primary objective of this study was to understand Minnesota pharmacists' attitudes about the profession's role in the opioid crisis, including perceptions on the pharmacist's public health and clinical roles within the crisis, views on the dispensing of naloxone, and attitudes toward harm reduction strategies including syringe access.Methods: This was a mixed‐method study that utilized an anonymous email survey containing Likert‐type responses which were quantitatively analyzed, as well as open comment boxes evaluated using Consensual Qualitative Research (CQR) methods. Pharmacists with a Minnesota license from all practice settings were invited to participate in the survey.Results: While the majority of participating pharmacists acknowledged a need within their communities to address the opioid epidemic agreeing that the profession should have a role in the community response, including provision of patient education and naloxone distribution, a small number of pharmacists believed that either the epidemic was not pertinent to their practice or pharmacy as a profession should not be involved. Concerns regarding naloxone included lack of support from other health professionals, time constraints in practice, and safety and liability concerns with naloxone.Conclusion: Considerable opportunity for increased pharmacist education on both opioid use disorder and the role of the pharmacist in harm reduction initiatives exists. Pharmacists from a wide variety of clinical practice settings have appreciable potential to influence the opioid crisis by embracing their clinical and public health roles.
11 January 2021 in Journal of Primary Care & Community Health
Introduction: The continuing opioid crisis poses unique challenges to remote and often under-resourced rural communities. Emergency medical service (EMS) providers serve a critical role in responding to opioid overdose for individuals living in rural or remote areas who experience opioid overdoses. They are often first at the scene of an overdose and are sometimes the only health care provider in contact with an overdose patient who either did not survive or refused additional care. As such, EMS providers have valuable perspectives to share on the causes and consequences of the opioid crisis in rural communities. Methods: EMS providers attending a statewide EMS conference serving those from greater Minnesota and surrounding states were invited to take a 2-question survey asking them to reflect upon what they believed to be the causes of the opioid crisis and what they saw as the solutions to the opioid crisis. Results were coded and categorized using a Consensual Qualitative Research approach. Results: EMS providers’ perceptions on causes of the opioid crisis were categorized into 5 main domains: overprescribing, ease of access, socioeconomic vulnerability, mental health concerns, and lack of resources and education. Responses focused on solutions to address the opioid crisis were categorized into 5 main domains: need for increased education, enhanced opioid oversight, increased access to treatment programs, alternative therapies for pain management, and addressing socioeconomic vulnerabilities. Conclusion: Along with the recognition that the opioid crisis was at least partially caused by overprescribing, rural EMS providers who participated in this study recognized the critical role of social determinants of health in perpetuating opioid-related harm. Participants in this study reported that education and increased access to treatment facilities and appropriate pain management, along with recognition of the role of social determinants of health in opioid dependency, were necessary steps to address the opioid crisis.
10 November 2020 in JACCP: Journal of the American College of Clinical Pharmacy
As emergency department (ED) crowding and patient boarding reach critical levels nationwide, the role of the emergency medicine pharmacist (EMP) must be both defined and safeguarded. While EMPs are increasingly valued for their contributions to acute care, their responsibilities often unintentionally expand during periods of operational strain, particularly when admitted patients remain in the ED for prolonged durations. EMPs should ideally be resourced to remain focused on time‐sensitive, high‐risk medication management where their expertise is most impactful and not be used as default providers for all pharmacotherapy needs during ED boarding. This perspective outlines our position on the ideal scope of EMP practice during times of congestion, advocating for clearly defined role boundaries, strategic collaboration with other pharmacy team members, and system‐level support to prevent dilution of emergency care. EMPs must be empowered to prioritize critical ED workflows, support resuscitations, and lead initiatives in education, protocol development, and patient safety, without being overextended by responsibilities that can be absorbed by other team members.